Related references
Note: Only part of the references are listed.Association of Baclofen With Falls and Fractures in Patients With CKD
Flory T. Muanda et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2021)
Population-Based Signals of Antidepressant Drug Interactions Associated With Unintentional Traumatic Injury
Charles E. Leonard et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Utilization Patterns of Skeletal Muscle Relaxants Among Commercially Insured Adults in the United States from 2006 to 2018
Yan Li et al.
PAIN MEDICINE (2021)
Pharmacoepidemiologic Screening of Potential Oral Anticoagulant Drug Interactions Leading to Thromboembolic Events
Meijia Zhou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Assessment of Physician Prescribing of Muscle Relaxants in the United States, 2005-2016
Samantha E. Soprano et al.
JAMA NETWORK OPEN (2020)
Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury
Charles E. Leonard et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Clopidogrel Drug Interactions and Serious Bleeding: Generating Real-World Evidence via Automated High-Throughput Pharmacoepidemiologic Screening
Charles E. Leonard et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Association of Receiving Multiple, Concurrent Fracture-Associated Drugs With Hip Fracture Risk
Rebecca T. Emeny et al.
JAMA NETWORK OPEN (2019)
Inhibition of In Vitro Metabolism of Opioids by Skeletal Muscle Relaxants
David E. Moody et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: I. Cardiovascular Drugs
Max de Vries et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2018)
Developmental Changes in Pharmacokinetics and Pharmacodynamics
John van den Anker et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
The risks of polypharmacy following spinal cord injury
Patrick Kitzman et al.
JOURNAL OF SPINAL CORD MEDICINE (2017)
Antidepressant Use and Recurrent Falls in Community-Dwelling Older Adults: Findings From the Health ABC Study
Zachary A. Marcum et al.
ANNALS OF PHARMACOTHERAPY (2016)
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016
Deborah Dowell et al.
MMWR RECOMMENDATIONS AND REPORTS (2016)
Varenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort study
Yasmina Molero et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Association of skeletal muscle relaxers and antihistamines on mortality, hospitalizations, and emergency department visits in elderly patients: a nationwide retrospective cohort study
Carlos A. Alvarez et al.
BMC GERIATRICS (2015)
Varenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort study
Yasmina Molero et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
A New Method to Classify Injury Severity by Diagnosis: Validation Using Workers' Compensation and Trauma Registry Data
Jeanne M. Sears et al.
JOURNAL OF OCCUPATIONAL REHABILITATION (2015)
P450-Based Drug-Drug Interactions of Amiodarone and its Metabolites: Diversity of Inhibitory Mechanisms
Matthew G. McDonald et al.
DRUG METABOLISM AND DISPOSITION (2015)
Risk of Injury Associated with Skeletal Muscle Relaxant Use in Older Adults
Michele M. Spence et al.
ANNALS OF PHARMACOTHERAPY (2013)
Risks and Benefits of Bladder Antimuscarinics Among Elderly Residents of Veterans Affairs Community Living Centers
Daniela C. Moga et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2013)
Varenicline and nicotine enhance GABAergic synaptic transmission in rat CA1 hippocampal and medial septum/diagonal band neurons
Dustin W. DuBois et al.
LIFE SCIENCES (2013)
Tizanidine (Zanaflex): A Muscle Relaxant That May Prolong the QT Interval by Blocking IKr
Nisrin Kaddar et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2012)
Opioid Metabolism
Howard S. Smith
MAYO CLINIC PROCEEDINGS (2012)
Injury in an Elderly Population Before and After Initiating a Skeletal Muscle Relaxant
Sarah J. Billups et al.
ANNALS OF PHARMACOTHERAPY (2011)
Characterizing the subjective and psychomotor effects of carisoprodol in healthy volunteers
James P. Zacny et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Decreases Systolic Blood Pressure in Japanese Hypertensive Patients with Type 2 Diabetes
Susumu Ogawa et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults
Eva Fernandez et al.
Pharmaceutics (2011)
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Carol Coupland et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Risk for Fractures with Centrally Acting Muscle Relaxants: An Analysis of a National Medicare Advantage Claims Database
Adam G. Golden et al.
ANNALS OF PHARMACOTHERAPY (2010)
Effect of pantoprazole and its interactions with vecuronium on the neuromuscular junction
Tejas K. Patel et al.
INDIAN JOURNAL OF PHARMACOLOGY (2010)
Empirical Bayes and semi-Bayes adjustments for a vast number of estimations
Ulf Stromberg
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2009)
Varenicline Gets Stronger Warnings About Psychiatric Problems, Vehicle Crashes
Bridget M. Kuehn
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Carisoprodol-Mediated Modulation of GABAA Receptors: In Vitro and in Vivo Studies
Lorie A. Gonzalez et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database
D. Gunnell et al.
BRITISH MEDICAL JOURNAL (2009)
The risk of traffic accidents after prescriptions of carisoprodol
Jorgen G. Bramness et al.
ACCIDENT ANALYSIS AND PREVENTION (2007)
How children's responses to drugs differ from adults
T Stephenson
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Share Paper
